The Cancer Letter

Inside information on cancer research and drug development

Vol.
16
No.
34
September 07, 1990Sep 07, 1990
Free
DOWNLOAD THE PDF

NCI Considers ‘Decentralization’ Of Group C To Provide Wider Access, Local Flexibility

In Brief: Broder Invokes Cancer Act Provision To Inform Hammer, Bush Of Potential Damage Of 32% Cut

Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs

Don’t Blame FDA For All Problems, Broder Says

Outside Experts Might Lengthen NDA Approval, Peck Asserts

Freement Lists Steps For Dealing With Disadvantaged

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account